Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients

BACKGROUND: The identification of reliable biomarkers in Parkinson’s disease (PD) would provide much needed diagnostic accuracy, a means of monitoring progression, objectively measuring treatment response, and potentially allowing patient stratification within clinical trials. Whilst the assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Priscilla, Kim, Woojin S., Halliday, Glenda M., Lewis, Simon J.G., Dzamko, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609717/
https://www.ncbi.nlm.nih.gov/pubmed/34151860
http://dx.doi.org/10.3233/JPD-212694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609717/
https://www.ncbi.nlm.nih.gov/pubmed/34151860
http://dx.doi.org/10.3233/JPD-212694

Ejemplares similares